488 related articles for article (PubMed ID: 33590521)
21. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
22. The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
Burkholder B; Wadood Z; Kassem AM; Ehrhardt D; Zomahoun D
Vaccine; 2023 Apr; 41 Suppl 1():A2-A11. PubMed ID: 34756614
[TBL] [Abstract][Full Text] [Related]
23. The Global Polio Eradication Initiative (GPEI) in Pakistan.
Nadeem NJ
J Pak Med Assoc; 2016 Nov; 66(11):1466-1471. PubMed ID: 27812070
[TBL] [Abstract][Full Text] [Related]
24. Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).
Thompson KM; Badizadegan K
Expert Rev Vaccines; 2024; 23(1):597-613. PubMed ID: 38813792
[TBL] [Abstract][Full Text] [Related]
25. Oral polio vaccine stockpile modeling: insights from recent experience.
Thompson KM; Kalkowska DA; Badizadegan K
Expert Rev Vaccines; 2023; 22(1):813-825. PubMed ID: 37747090
[TBL] [Abstract][Full Text] [Related]
26. Polio by the Numbers-A Global Perspective.
Badizadegan K; Kalkowska DA; Thompson KM
J Infect Dis; 2022 Oct; 226(8):1309-1318. PubMed ID: 35415741
[TBL] [Abstract][Full Text] [Related]
27. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame.
Badizadegan K; Kalkowska DA; Thompson KM
Med Decis Making; 2023; 43(7-8):850-862. PubMed ID: 37577803
[TBL] [Abstract][Full Text] [Related]
28. Anti-polio vaccinations in the third millennia.
Icardi G; Tassinari F
Ann Ig; 2018; 30(4 Supple 1):11-15. PubMed ID: 30062374
[TBL] [Abstract][Full Text] [Related]
29. [Advances in researches of serotype 2 novel oral polio vaccine].
Chen SY; Li Y; Yang JS; Yin XX
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):413-417. PubMed ID: 33730837
[TBL] [Abstract][Full Text] [Related]
30. [The role of Sabin inactivated poliovirus vaccine in the final phase of global polio eradication].
Dong SZ; Zhu WB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1032-1035. PubMed ID: 28057104
[TBL] [Abstract][Full Text] [Related]
31. Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries.
Blankenhorn AL; Cernuschi T; Zaffran MJ
J Infect Dis; 2017 Jul; 216(suppl_1):S52-S56. PubMed ID: 28838169
[TBL] [Abstract][Full Text] [Related]
32. Polio eradication initiative in India: deconstructing the GPEI.
Sathyamala C; Mittal O; Dasgupta R; Priya R
Int J Health Serv; 2005; 35(2):361-83. PubMed ID: 15932011
[TBL] [Abstract][Full Text] [Related]
33. Global Polio Eradication - Way Ahead.
Bahl S; Bhatnagar P; Sutter RW; Roesel S; Zaffran M
Indian J Pediatr; 2018 Feb; 85(2):124-131. PubMed ID: 29302865
[TBL] [Abstract][Full Text] [Related]
34. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020.
Darwar R; Biya O; Greene SA; Jorba J; Al Safadi M; Franka R; Wiesen E; Durry E; Pallansch MA
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A25-A34. PubMed ID: 36863925
[TBL] [Abstract][Full Text] [Related]
35. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication.
Kew O; Pallansch M
Annu Rev Virol; 2018 Sep; 5(1):427-451. PubMed ID: 30001183
[TBL] [Abstract][Full Text] [Related]
36. Costs and benefits of polio eradication: a long-run global perspective.
Khan MM; Ehreth J
Vaccine; 2003 Jan; 21(7-8):702-5. PubMed ID: 12531344
[TBL] [Abstract][Full Text] [Related]
37. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
Patel M; Cochi S
J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
[TBL] [Abstract][Full Text] [Related]
38. Polio inactivated vaccine costs into routine childhood immunization in Brazil.
Sartori AM; Vicentine MP; Gryninger LC; Soárez PC; Novaes HM
Rev Saude Publica; 2015; 49():8. PubMed ID: 25741645
[TBL] [Abstract][Full Text] [Related]
39. Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative.
Thompson KM; Kalkowska DA; Badizadegan K
Gates Open Res; 2022; 6():5. PubMed ID: 35280345
[No Abstract] [Full Text] [Related]
40. An economic analysis of poliovirus risk management policy options for 2013-2052.
Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Thompson KM
BMC Infect Dis; 2015 Sep; 15():389. PubMed ID: 26404632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
